Staff Accountant

Location
Louisville, KY
Posted
Jun 10, 2021
Ref
1033
Required Education
Bachelors Degree
Position Type
Full time
Job Title: Staff Accountant

Schedule: Full-time

Location: Louisville, KY

Classification: Salaried, Exempt

Reports to: Director, Finance and Controller

Direct Reports:N/A

Position Summary:

Reporting to the Director, Finance and Controller, the Staff Accountant will perform a number of accounting functions including preparing monthly journal entries and reconciliations, processing AP transactions and supporting payroll operations.

Principal Duties and Responsibilities:
  • Preparation of monthly journal entries
  • Work with accounting team to identify additional areas to automate journal entries
  • Monthly balance sheet reconciliations
  • Assist with annual audits and quarterly review
  • Review automated treasury entries for accuracy
  • Reconcile monthly bank activity
  • Reconcile monthly credit card activity
  • Close coordination with supply chain/purchasing function
  • Vendor setup/maintenance
  • Ensure accuracy of vendor invoices to general ledger
  • Responsible for vendor correspondence
  • Coordinate annual 1099 filings
  • Employee expense reimbursement system maintenance/setup
  • Work with departmental leadership to improve AP and purchasing process for company as a whole
  • Ensure accuracy of payroll information
  • Basic knowledge of tax withholding, payroll deductions (including pre-tax deductions), HSA accounts, FSA accounts, and dependent care accounts
  • Semi-monthly 401k plan reporting
  • Reconciliation of FSA/HRA monthly activity
  • Employee benefits review and maintenance
  • Ad-hoc projects and reporting as necessary


Minimum Education, Training, and Experience Required:
  • Bachelor’s degree required in accounting or other business-related major; advanced degree in related field preferred
  • CPA preferred
  • 1-3 years of relevant work experience. Public accounting firm experience a plus.


Additional Qualifications
  • Working knowledge of US GAAP and experience working in accounting software (Sage Intacct experience a plus).
  • Excellent written and oral communication skills.
  • Strong interpersonal skills and ability to interact with many types of professionals.
  • Demonstrated ability to adapt to changing priorities and schedules.
  • Strong attention to detail and organizational skills.
  • Self-starter with ability to manage many projects at once, work well under tight deadlines, prioritize tasks appropriately, and problem solve.
  • Strong business and financial acumen as well as analytical skills.
  • Strong work ethic.
  • Demonstrated diplomacy, an “internal client” focus, and commitment to confidentiality.
  • Strong technology skills including proficiency with Microsoft Office products such as Excel, Word, PowerPoint and Outlook.


Physical Requirements:
  • Prolonged periods of sitting at a desk and working on a computer.
  • Must be able to lift 15 pounds at times.
  • Must be able to access and navigate each department at the organization’s facilities.


Benefits:
  • Health insurance
  • Dental insurance
  • Vision insurance
  • Paid time off 25 days
  • Stock Options
  • 401k


Talaris Therapeutics, Inc. (“Talaris”) is a late-clinical stage, publicly traded (Nasdaq Global Market: TALS), biotechnology company that is developing an innovative method of allogenic hematopoietic stem cell transplantation that we believe has the potential to transform the standard of care in sold organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant immune and metabolic disorders. In a ground-breaking, phase 2 study, our lead therapy, FCR001, enabled 70% of living donor kidney transplant recipients to be weaned off all immunosuppression within 12 months of their kidney transplant without rejecting their donated organ. We have followed these patients for an average of over six years since their transplant, and not a single patient who was tolerized in our phase 2 study has subsequently had to resume immunosuppression. We are currently enrolling patients in FREEDOM-1, a randomized, controlled, open-label Phase 3 registration trial in the United States of FCR001 in 120 adult living donor kidney transplant (LDKT) recipients, and in the second half of 2021 we will be initiating FREEDOM-2, in which we will evaluate the potential of FCR001 to induce durable immune tolerance in patients who have previously received a kidney from a living donor, as well as FREEDOM-3 in which we will evaluate the safety and efficacy of FCR001 in adults with a severe form of scleroderma, a debilitating autoimmune disease. We currently have approximately 100 employees and have a corporate office in Boston, MA in addition to our cell processing facility in Louisville, KY.